Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome
- 11 August 2003
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 121A (3), 219-224
- https://doi.org/10.1002/ajmg.a.20234
Abstract
Contradictory findings have been recently published on the evaluation of genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR 677 C→T) and methionine synthase reductase (MTRR 66 A→G) as risk factors for having a child with Down syndrome (DS); however, the influence of polymorphisms of methionine synthase (MTR 2756 A→G) and of MTHFR 1298 A→C has never been evaluated. In this study, the risk of being a DS case or having a DS child (case mother) was studied by multiple logistic regression analysis of the independent and combined genotypes and of plasma homocysteine, folates, and vitamin B12 in 92 DS cases and 140 control subjects as well as in 63 case mothers and 72 age‐matched control mothers from Sicily. (The MTHFR 677 T allele frequency was not different in DS cases and case mothers, compared to the respective control groups). After adjustment for age, total homocysteine (t‐Hcys) and MTR 2756 AG/GG genotype were significant risk factors for having a DS child, with odds ratio (OR) of 6.7 (95% CI: 1.4–32.0, P = 0.016) and of 3.5 (95% CI: 1.2–10.9, P = 0.028), respectively. By comparison, MTR 2756 AG/GG genotype increased significantly the risk of being a DS case, with an OR of 3.8 (95% CI: 1.4–10.5, P = 0.009). The double heterozygosity MTR 2756 AG/MTRR 66 AG was the single combined genotype that was a significant risk factor for having a DS child, with an OR estimated at 5.0 (95% CI: 1.1–24.1), after adjustment for t‐Hcys. In conclusion, our results provide evidences that homocysteine and MTR genetic polymorphism are two potent risk factors for mothers to have a DS child in Sicily.Keywords
This publication has 22 references indexed in Scilit:
- Folate Deficiency and the Molecular Determinants of Chromosome Instability: Possible Link to Meiotic Nondisjunction and Down SyndromePublished by Springer Science and Business Media LLC ,2003
- Methylenetetrahydrofolate Reductase Polymorphism in the Etiology of Down SyndromePediatric Research, 2002
- Maternal Folate Polymorphisms and the Etiology of Human NondisjunctionAmerican Journal of Human Genetics, 2001
- Hyperhomocysteinemia Is Related to Residual Glomerular Filtration and Folate, but not to Methylenetetrahydrofolate-Reductase and Methionine Synthase Polymorphisms, in Supplemented End-Stage Renal Disease Patients Undergoing Hemodialysiscclm, 2001
- Polymorphisms in Genes Involved in Folate Metabolism as Maternal Risk Factors for Down SyndromeAmerican Journal of Human Genetics, 2000
- Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defectsAmerican Journal of Medical Genetics, 1999
- Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular DiseaseCirculation, 1998
- Human Methionine SynthaseJournal of Biological Chemistry, 1997
- Spina bifida, 677T→C mutation, and role of folateThe Lancet, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995